...
首页> 外文期刊>International journal of infectious diseases : >Seroprevalence of hepatitis B and hepatitis C among blood donors in Sierra Leone: A multi-year retrospective study
【24h】

Seroprevalence of hepatitis B and hepatitis C among blood donors in Sierra Leone: A multi-year retrospective study

机译:塞拉利昂献血者乙型肝炎和丙型肝炎的Seroprevalence:多年回顾性研究

获取原文
           

摘要

Objectives In Sierra Leone, very little data are available on hepatitis B virus (HBV) and hepatitis C virus (HCV) prevalence. Blood donor screening permits estimation of the prevalence of transfusion transmissible infections in a general open population. We analyzed blood donor data in Sierra Leone to estimate national viral hepatitis prevalence and identify risk factors for hepatitis infection among the donor population. Methods We conducted a retrospective data analysis in five government hospitals. We collected HBV and HCV screening results, donor demographics, and donation type (family replacement or voluntary donor; first-time or repeat). Univariate and multivariate analyses were performed to determine associations between infections and socio-demographic factors. Results The number of donors screened was 29,713. The overall prevalence was: 10.8% (3200) for HBV and 1.2% (357) for HCV. HBV infection was most strongly associated with male sex ( p : 0.0001) and younger age ( p : 0.0004 for the 22–27 age group). Both HBV and HCV infection were higher in certain locations. Conclusion Our findings stress the presence of viral hepatitis infection throughout the country and the need to invest in safe blood services, vaccination and treatment of viral hepatitis at the national level.
机译:在塞拉利昂的目标中,乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)患病率均有很少的数据。血液供体筛选允许估计一般公开人口中输血传染性感染的患病率。我们分析了塞拉利昂的血液供体数据,以估计捐助人群中肝炎感染的国家病毒性肝炎患病率并确定患有肝炎感染的危险因素。方法我们在五家政府医院进行了回顾性数据分析。我们收集了HBV和HCV筛选结果,捐助人口统计学和捐赠类型(家庭替代或自愿捐赠者;第一次或重复)。进行单变量和多变量分析,以确定感染与社会人口因子之间的关联。结果筛选的供体数为29,713。总体流行率为:HBV为10.8%(3200),HCV为1.2%(357)。 HBV感染与男性(P:<0.0001)和较小的年龄最强烈(P:<0.0004,22-27岁年龄组)。某些位置的HBV和HCV感染均较高。结论我们的研究结果强调了全国各地病毒肝炎感染的存在,需要在国家一级投资安全血液服务,疫苗接种和治疗病毒性肝炎。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号